Sylvie Fabrega

1.8k total citations
29 papers, 591 citations indexed

About

Sylvie Fabrega is a scholar working on Molecular Biology, Physiology and Hematology. According to data from OpenAlex, Sylvie Fabrega has authored 29 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Physiology and 6 papers in Hematology. Recurrent topics in Sylvie Fabrega's work include Lysosomal Storage Disorders Research (5 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Cellular transport and secretion (4 papers). Sylvie Fabrega is often cited by papers focused on Lysosomal Storage Disorders Research (5 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Cellular transport and secretion (4 papers). Sylvie Fabrega collaborates with scholars based in France, United States and Australia. Sylvie Fabrega's co-authors include François‐Jérôme Authier, Noufϊssa Oudrhiri, Jean Navarro, Patrick Durand, Jean‐Paul Mornon, Pierre Lehn, Gilbert Briand, Mostafa Kouach, Bernard Henrissat and Mourad Métioui and has published in prestigious journals such as Nature, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Sylvie Fabrega

28 papers receiving 587 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvie Fabrega France 13 341 106 100 92 79 29 591
Sarah C. Mutka United States 14 493 1.4× 83 0.8× 119 1.2× 86 0.9× 54 0.7× 22 819
Evelyn Plets Belgium 10 275 0.8× 79 0.7× 150 1.5× 44 0.5× 28 0.4× 13 477
Ana Mitrović Slovenia 15 340 1.0× 83 0.8× 50 0.5× 58 0.6× 41 0.5× 42 837
Hugh P. Morgan United Kingdom 16 423 1.2× 255 2.4× 118 1.2× 143 1.6× 42 0.5× 24 844
Vera Baraznenok Sweden 15 584 1.7× 37 0.3× 63 0.6× 50 0.5× 54 0.7× 21 865
Xueji Wu China 17 494 1.4× 186 1.8× 38 0.4× 76 0.8× 36 0.5× 32 918
Clara L. Oeste Spain 14 361 1.1× 139 1.3× 73 0.7× 82 0.9× 44 0.6× 27 666
Huadong Pei China 16 910 2.7× 75 0.7× 54 0.5× 64 0.7× 69 0.9× 23 1.0k
D E Wylie United States 15 297 0.9× 203 1.9× 77 0.8× 42 0.5× 78 1.0× 18 647
Linhui Zhai China 19 681 2.0× 71 0.7× 41 0.4× 113 1.2× 67 0.8× 48 941

Countries citing papers authored by Sylvie Fabrega

Since Specialization
Citations

This map shows the geographic impact of Sylvie Fabrega's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Fabrega with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Fabrega more than expected).

Fields of papers citing papers by Sylvie Fabrega

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Fabrega. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Fabrega. The network helps show where Sylvie Fabrega may publish in the future.

Co-authorship network of co-authors of Sylvie Fabrega

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Fabrega. A scholar is included among the top collaborators of Sylvie Fabrega based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Fabrega. Sylvie Fabrega is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fabrega, Sylvie, et al.. (2025). ERAP1-dependent extreme antigen processing efficacy can govern MHC class I expression hierarchy. The Journal of Immunology. 214(6). 1147–1159. 1 indexed citations
2.
Calbiac, Hortense de, Sorana Ciura, Apolline Imbard, et al.. (2024). TANGO2-related rhabdomyolysis symptoms are associated with abnormal autophagy functioning. SHILAP Revista de lepidopterología. 3(1). 3 indexed citations
3.
Chalabi, Smahane, Agnès Legrand, Marina Daouya, et al.. (2023). Co-Transplantation of Barcoded Lymphoid-Primed Multipotent (LMPP) and Common Lymphocyte (CLP) Progenitors Reveals a Major Contribution of LMPP to the Lymphoid Lineage. International Journal of Molecular Sciences. 24(5). 4368–4368.
4.
Daubon, Thomas, Joris Guyon, Sylvie Fabrega, et al.. (2022). Glioblastoma cell motility depends on enhanced oxidative stress coupled with mobilization of a sulfurtransferase. Cell Death and Disease. 13(10). 913–913. 20 indexed citations
5.
Lagarde, Nathalie, Sylvie Fabrega, Bruno O. Villoutreix, et al.. (2022). Machine learning-driven identification of drugs inhibiting cytochrome P450 2C9. PLoS Computational Biology. 18(1). e1009820–e1009820. 25 indexed citations
6.
Cheval, Lydie, Yannick Marie, Sylvie Fabrega, et al.. (2022). miR-324-5p and miR-30c-2-3p Alter Renal Mineralocorticoid Receptor Signaling under Hypertonicity. Cells. 11(9). 1377–1377. 6 indexed citations
7.
Courtois, G., Chantal Brouzes, Juliette Pulman, et al.. (2021). Biallelic mutations in the <i>SARS2</i> gene presenting as congenital sideroblastic anemia. Haematologica. 106(12). 3202–3205. 3 indexed citations
8.
Oberkampf, Marine, Tristan Félix, Pierre Rosenbaum, et al.. (2019). Persistence of Integrase-Deficient Lentiviral Vectors Correlates with the Induction of STING-Independent CD8+ T Cell Responses. Cell Reports. 26(5). 1242–1257.e7. 26 indexed citations
9.
Treins, Caroline, et al.. (2017). ZRF 1 is a novel S6 kinase substrate that drives the senescence programme. The EMBO Journal. 36(6). 736–750. 31 indexed citations
10.
Martin, Emmanuel, Sylvia Sanquer, Christelle Lenoir, et al.. (2014). CTP synthase 1 deficiency in humans reveals its central role in lymphocyte proliferation. Nature. 510(7504). 288–292. 146 indexed citations
11.
Moal, Vanessa Liévin‐Le, Isabelle Beau, Imad Kansau, et al.. (2011). Apical expression of human full-length hCEACAM1-4L protein renders the Madin Darby Canine Kidney cells responsive to lipopolysaccharide leading to TLR4-dependent Erk1/2 and p38 MAPK signalling. Cellular Microbiology. 13(5). 764–785. 5 indexed citations
12.
Merlen, Clémence, et al.. (2007). Role of receptor‐mediated endocytosis, endosomal acidification and cathepsin D in cholera toxin cytotoxicity. FEBS Journal. 274(10). 2614–2629. 10 indexed citations
13.
Merlen, Clémence, Sylvie Fabrega, Bernard Desbuquois, Cecilia G. Unson, & François‐Jérôme Authier. (2006). Glucagon‐mediated internalization of serine‐phosphorylated glucagon receptor and Gsα in rat liver. FEBS Letters. 580(24). 5697–5704. 25 indexed citations
14.
Merlen, Clémence, et al.. (2005). Proteolytic activation of internalized cholera toxin within hepatic endosomes by cathepsin D. FEBS Journal. 272(17). 4385–4397. 11 indexed citations
15.
Authier, François‐Jérôme, Mourad Métioui, Sylvie Fabrega, Mostafa Kouach, & Gilbert Briand. (2002). Endosomal Proteolysis of Internalized Insulin at the C-terminal Region of the B Chain by Cathepsin D. Journal of Biological Chemistry. 277(11). 9437–9446. 58 indexed citations
16.
Brooks, Doug A., Sylvie Fabrega, Leanne K. Hein, et al.. (2001). Glycosidase active site mutations in human  -L-iduronidase. Glycobiology. 11(9). 741–750. 24 indexed citations
17.
Fabrega, Sylvie, Patrick Durand, Patrice Codogno, et al.. (2000). Human glucocerebrosidase: heterologous expression of active site mutants in murine null cells. Glycobiology. 10(11). 1217–1224. 25 indexed citations
18.
Durand, Patrick, Pierre Lehn, Isabelle Callebaut, et al.. (1997). Active-site motifs of lysosomal acid hydrolases: invariant features of clan GH-A glycosyl hydrolases deduced from hydrophobic cluster analysis. Glycobiology. 7(2). 277–284. 51 indexed citations
19.
Douay, Luc, et al.. (1992). Purging of acute lymphoblastic leukemia by long-term marrow culture.. PubMed. 377. 205–13; discussion 214. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026